ストックスクリーナーアプリを入手
20.30
0.45%
0.09
アフターアワーズ：
20.25
-0.05
-0.25%
Immunome Inc (IMNM) 最新ニュース
Director Philip Wagenheim Sells 65,000 Shares of Immunome Inc (I - GuruFocus
Immunome Inc: director Wagenheim sells $1.3m in shares By Investing.com - Investing.com South Africa
Immunome (NASDAQ:IMNM) Director Philip Wagenheim Sells 28,200 Shares - MarketBeat
Philip Wagenheim Sells 36,800 Shares of Immunome (NASDAQ:IMNM) Stock - MarketBeat
Immunome Inc: director Wagenheim sells $1.3m in shares - Investing.com
Immunome Director Sold Shares Worth Over $1.3M - TradingView
Immunome (IMNM) director sells 65,000 shares in open market - Stock Titan
IMNM PE Ratio & Valuation, Is IMNM Overvalued - Intellectia AI
Immunome Inc stock surges on breakthrough oncology data, drawing DACH biotech investor interest - AD HOC NEWS
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Form 144 Immunome Inc. For: 20 March By Investing.com - Investing.com Australia
Smart Money: Is Immunome Inc forming a breakout patternQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Form 144 Immunome Inc. For: 20 March - Investing.com
[144] Immunome Inc. SEC Filing - Stock Titan
Behavioral Patterns of IMNM and Institutional Flows - Stock Traders Daily
HC Wainwright & Co. initiates coverage of Immunome (IMNM) with buy recommendation - MSN
This Sezzle analyst begins coverage on a bullish note; here are top 3 initiations for Thursday - MSN
Stephens & Co. Maintains Immunome (IMNM) Overweight Recommendation - MSN
Immunome Inc Stock (ISIN: US45254C1062) Eyes Upside as Lock-Up Expires Today Amid Short-Term Buy Sig - AD HOC NEWS
Forecast Cut: What is the long term forecast for Immunome Inc stockBond Market & Fast Gain Stock Trading Tips - baoquankhu1.vn
Certain Stock Options of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2026. - marketscreener.com
Certain Common Stock of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2026. - marketscreener.com
Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% - AOL.com
Pivotal bioVenture Partners Investment Advisor LLC Invests $5.88 Million in Immunome, Inc. $IMNM - MarketBeat
Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing - AOL.com
Loss Report: Is Immunome Inc forming a breakout pattern2026 Risk Factors & Weekly Stock Breakout Alerts - baoquankhu1.vn
Bienaime buys Immunome (IMNM) shares worth $43,670 - Investing.com Nigeria
Insider Buying: Jean Bienaime Acquires Additional Shares of Immu - GuruFocus
Bienaime buys Immunome (IMNM) shares worth $43,670 By Investing.com - Investing.com South Africa
Immunome (NASDAQ:IMNM) Director Acquires $21,550.00 in Stock - MarketBeat
Immunome (IMNM) director buys 2,000 shares in open market - Stock Titan
Craig-Hallum Initiates Coverage of Immunome (IMNM) with Buy Recommendation - MSN
A Look At Immunome (IMNM) Valuation After Narrower 2025 Loss And New US$156 Million Shelf Registration - simplywall.st
Immunome: Upcoming NDA, Valuation, And Investment Case (NASDAQ:IMNM) - Seeking Alpha
Immunome (IMNM) to Release Earnings on Wednesday - MarketBeat
(IMNM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Immunome (NASDAQ:IMNM) Downgraded by Wall Street Zen to "Sell" - MarketBeat
Is Immunome Inc forming a breakout patternJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Immunome (IMNM) - The Globe and Mail
Did Reduced 2025 Losses and NDA Plans Just Shift Immunome's (IMNM) Investment Narrative? - finance.yahoo.com
Whale Trades: How do insiders feel about Immunome IncMarket Sentiment Review & Entry and Exit Point Strategies - baoquankhu1.vn
HC Wainwright Brokers Raise Earnings Estimates for Immunome - MarketBeat
Immunome (IMNM) TTM Net Loss Of US$212 Million Reinforces Bearish Profitability Narratives - Sahm
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
HC Wainwright Analysts Boost Earnings Estimates for Immunome - MarketBeat
IMNM: Stephens & Co. Lowers Price Target to $30, Maintains Overw - GuruFocus
Immunome (IMNM): Craig-Hallum Raises Price Target to $36.00 and - GuruFocus
Immunome (NASDAQ:IMNM) Price Target Raised to $36.00 - MarketBeat
Stephens Cuts Immunome (NASDAQ:IMNM) Price Target to $30.00 - MarketBeat
Decoding Immunome Inc (IMNM): A Strategic SWOT Insight - GuruFocus
Immunome (IMNM) Reports Wider Losses and Revenue Decline - GuruFocus
Immunome 2025 Net Loss Narrows - marketscreener.com
1.82%
大文字化:
|
ボリューム (24 時間):